uftoral has been researched along with estramustine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaza, H; Tsukamoto, S | 1 |
Arai, Y; Ichikawa, Y; Inoue, H; Kamoi, K; Koide, T; Miki, T; Miura, H; Nakai, Y; Nishimura, K; Nonomura, N; Okuyama, A; Shimizu, K; Sugao, H; Takaha, N; Takatera, H; Tokizane, T; Uchida, K; Ukimura, O; Yamaguchi, S | 1 |
2 review(s) available for uftoral and estramustine
Article | Year |
---|---|
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
1 trial(s) available for uftoral and estramustine
Article | Year |
---|---|
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |